These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 87368)

  • 1. A novel surface antigen on lymphoid cells transformed by Epstein-Barr virus.
    Hinuma Y; Sakamoto K
    IARC Sci Publ (1971); 1978; (24 Pt 1):249-51. PubMed ID: 87368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K; Hinuma Y
    J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.
    Franklin SM; North JR; Morgan AJ; Epstein MA
    J Gen Virol; 1981 Apr; 53(Pt 2):371-6. PubMed ID: 6167667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
    Maeda M; Sairenji T; Hinuma Y
    Microbiol Immunol; 1979; 23(12):1189-97. PubMed ID: 231730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic identification of Epstein-Barr virus early antigen in a P3HR-1 cell extract.
    Veltri RW; Wainwright WH; Sprinkle PM
    J Natl Cancer Inst; 1976 Aug; 57(2):245-53. PubMed ID: 187767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.
    Szigeti R; Sulitzeanu D; Henle G; Henle W; Klein G
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4178-82. PubMed ID: 6330746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of early and late components of Epstein-Barr virus-associated membrane antigen in Daudi cells superinfected with P3HR-1 virus.
    Sairenji T; Hinuma Y; Sekizawa T; Yoshida M
    J Gen Virol; 1978 Jan; 38(1):111-20. PubMed ID: 202665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human B cell line deficient in the expression of B cell-specific glycoproteins (GP 27,35).
    Trowbridge IS; Hyman R; Klein G
    Eur J Immunol; 1977 Sep; 7(9):640-5. PubMed ID: 72671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Papain solubilization of the Epstein-Barr virus-induced membrane antigen.
    Pearson GR; Qualtiere LF
    J Virol; 1978 Oct; 28(1):344-51. PubMed ID: 81320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells.
    Qualtiere LF; Pearson GR
    Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional association of class II antigens with cell surface binding of Epstein-Barr virus.
    Reisert PS; Spiro RC; Townsend PL; Stanford SA; Sairenji T; Humphreys RE
    J Immunol; 1985 Jun; 134(6):3776-80. PubMed ID: 2985696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of transforming and nontransforming Epstein-Barr virus in high passages of P3HR-1 cell lines.
    Gerber P; Ablashi D; Magrath I; Armstrong G; Andersen P; Trach L
    J Natl Cancer Inst; 1982 Sep; 69(3):585-90. PubMed ID: 6287082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to intermediate filament-associated, Epstein-Barr virus-induced early antigen.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    J Immunol; 1987 Apr; 138(8):2645-52. PubMed ID: 2435803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Epstein-Barr virus strain differences with monoclonal antibody to a membrane glycoprotein.
    Qualtiere LF; Chase R; Vroman B; Pearson GR
    Proc Natl Acad Sci U S A; 1982 Jan; 79(2):616-20. PubMed ID: 6176998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late components of Epstein-Barr virus-associated membrane antigen in superinfected Daudi cells and their reactivity with sera from nasopharyngeal carcinoma patients.
    Hinuma Y; Sairenji T; Maeda M
    IARC Sci Publ (1971); 1978; (20):385-90. PubMed ID: 215521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.